End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.218 PLN | -0.91% | +1.16% | -14.84% |
Feb. 14 | InventionMed S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Feb. 14 | InventionMed S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 10.45K 2.58K | Sales 2022 | 4.06K 1.01K | Capitalization | 27.78M 6.87M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | -22M -5.44M | EV / Sales 2021 | 3,442 x |
Net cash position 2021 | 5.65M 1.4M | Net cash position 2022 | 1.64M 406K | EV / Sales 2022 | 6,431 x |
P/E ratio 2021 |
-61.7
x | P/E ratio 2022 |
-1.25
x | Employees | 7 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 56.1% |
1 day | -0.91% | ||
1 week | +1.16% | ||
Current month | -3.54% | ||
1 month | -6.44% | ||
3 months | -16.79% | ||
6 months | -5.22% | ||
Current year | -14.84% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-01-28 | |
Maciej Zegarski
COO | Chief Operating Officer | - | - |
Andrzej Szurek
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Lidia Rudnicka
BRD | Director/Board Member | - | 18-01-28 |
Cezary Jasinski
PRN | Corporate Officer/Principal | - | - |
Director/Board Member | 41 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.218 | -0.91% | 115,543 |
24-04-22 | 0.22 | +4.27% | 284,518 |
24-04-19 | 0.211 | -2.09% | 179,894 |
24-04-18 | 0.2155 | -2.05% | 137,026 |
24-04-17 | 0.22 | +2.09% | 84,718 |
End-of-day quote Warsaw S.E., April 22, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-14.84% | 10.97M | |
+4.46% | 32.45B | |
+12.62% | 7.26B | |
+21.27% | 3.84B | |
-8.78% | 3.43B | |
-24.45% | 1.31B | |
-35.53% | 1.11B | |
+2.79% | 919M | |
-24.21% | 856M | |
-39.85% | 840M |
- Stock Market
- Equities
- INM Stock